Literature DB >> 27449327

Therapeutic effect of dioscin on collagen-induced arthritis through reduction of Th1/Th2.

Yachun Guo1, Enhong Xing2, Hongru Song3, Guiying Feng4, Xiujun Liang5, Gao An6, Xiaofei Zhao6, Mi Wang6.   

Abstract

The aim of this study was to detect the therapeutic effect of dioscin on collagen-induced arthritis (CIA). Mice model of CIA was induced by chicken collagen II and arthritis index was assessed. After suspension of dioscin (100mg/kg/d) or triptolide was intragastrically administered, the left paw swelling and body weight of each mouse were measured. Then tissue samples were assayed by histopathological analysis. The levels of Th1 and Th2 were detected by flow cytometry. The expression of p-STAT1, p-STAT4 and p-STAT6 was demonstrated by western blot analysis, and T-bet and GATA-3 expression was detected by RT-PCR. The paw swelling and arthritis index were decreased and body weight was increased in the high dose of dioscin group compared to the model group (P<0.05). Histopathological analysis revealed that the damage of synovium tissue in dioscin and triptolide group alleviated. The ratio of Th1/Th2 in the dioscin group (0.82±0.24) and triptolide group (0.99±0.44) was lower than that in the model group (1.84±0.70, P<0.05). Additionally, p-STAT4 expression was decreased, and both p-STAT6 and GATA3 expression was increased in the dioscin group than that in the model group (P<0.05). Dioscin might have some therapeutic effects on CIA through regulating the proportion of Th1/Th2 cells, which could reduce the expression of p-STAT4, increase the expression of p-STAT6 and GATA3 in the synovial tissue.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Collagen-induced arthritis; Dioscin; Th1/Th2

Mesh:

Substances:

Year:  2016        PMID: 27449327     DOI: 10.1016/j.intimp.2016.06.029

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  7 in total

1.  Assessment of immunological profile in ankylosing spondylitis patients following a clinical trial with guluronic acid (G2013), as a new NSAID with immunomodulatory properties.

Authors:  Seyed Shahabeddin Mortazavi-Jahromi; Sepideh Nazeri; Fahimeh Jafarnezhad-Ansariha; Mona Oraei; Abbas Mirshafiey
Journal:  Immunol Res       Date:  2019-02       Impact factor: 2.829

2.  Berberis lycium fruit extract and its phytoconstituents berberine and rutin mitigate collagen-CFA-induced arthritis (CIA) via improving GSK3β/STAT/Akt/MAPKs/NF-κB signaling axis mediated oxi-inflammation and joint articular damage in murine model.

Authors:  Anamika Sharma; Narendra Vijay Tirpude; Neha Bhardwaj; Dinesh Kumar; Yogendra Padwad
Journal:  Inflammopharmacology       Date:  2022-03-07       Impact factor: 4.473

3.  Dissecting the Underlying Pharmaceutical Mechanism of Chinese Traditional Medicine Yun-Pi-Yi-Shen-Tong-Du-Tang Acting on Ankylosing Spondylitis through Systems Biology Approaches.

Authors:  Duoli Xie; Lin Huang; Guanghui Zhao; Yiran Yu; Jiawei Gao; Haichang Li; Chengping Wen
Journal:  Sci Rep       Date:  2017-10-18       Impact factor: 4.379

Review 4.  Applicability and implementation of the collagen-induced arthritis mouse model, including protocols (Review).

Authors:  Jing Luan; Zhifang Hu; Jianghong Cheng; Ruisan Zhang; Peng Yang; Huifang Guo; Gang Nan; Na Guo; Xingchun Gou
Journal:  Exp Ther Med       Date:  2021-07-01       Impact factor: 2.447

5.  Isolation of dioscin-related steroidal saponin from the bulbs of Allium paradoxum L. with leishmanicidal activity.

Authors:  Fatemeh Rezaee; Behzad Zolfaghari; Masoud Sadeghi Dinani
Journal:  Res Pharm Sci       Date:  2018-10

6.  Therapeutic Effect of Xuebijing, a Traditional Chinese Medicine Injection, on Rheumatoid Arthritis.

Authors:  Shutong Li; Hongxing Wang; Qinbao Sun; Bin Liu; Xiaotian Chang
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-28       Impact factor: 2.629

7.  Therapeutic Effect of Exogenous Regulatory T Cells on Collagen-induced Arthritis and Rheumatoid Arthritis.

Authors:  Shutong Li; Hongxing Wang; Hui Wu; Xiaotian Chang
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.